Did you know that you can optimise your noise-cancellation settings? Noise-cancellation technology allows users to tweak settings by running an analysis of new and different conditions. The optimise ...
1 Leggy black nightstands with a small drawer for function contrast the wallpaper and set off the trim on the lampshades and art frames. The sensuously curved double sconces are from Lulu and Georgia.
There are also aesthetic upgrades across the board. Apple has added new Unity Rhythm wallpapers, as well as interactive watch faces for the Apple Watch. These wallpapers move once you unlock your ...
DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...
Metsera is a clinical-stage biotechnology company developing injectable and oral treatments for obesity and related conditions, the filing shows. The company’s investors include affiliates of ...
The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin condition known as chronic spontaneous urticaria, or chronic hives.
“Frictionless” is one of those tech-world ideals that sounds more promising than it actually is. What if you could press a button and get all the music in the world? And what if that music ...
Sam Altman, pictured at President Donald Trump's inauguration, is contributing to another round of funding for Retro Biosciences. © 2025 Fortune Media IP Limited ...
The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics revealing plans to go public while Hong Kong-listed Ascentage Pharma joins ...
Canada has long punched above its weight in life sciences and biotechnology, with many of the fundamental discoveries that underpin today’s important blockbuster drugs and therapeutic approaches ...
EU targets AI, biotech, green tech, advance materials sectors Draghi report said EU is falling behind US and China France, Trump push EU to cut business red tape EU plans include 25% reduction of ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly support late-stage clinical development of two medicines that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results